2012•American Heart JournalRequires access

Pharmacodynamic effect of prasugrel 5 mg vs clopidogrel 150 mg in elderly patients with high on-clopidogrel platelet reactivity

Dimitrios Alexopoulos, Ioanna Xanthopoulou, Theodora-Eleni Plakomyti, Konstantinos C. Theodoropoulos, Eleni Mavronasiou, Αναστασία Δαμέλου, George Hahalis, Periklis Davlouros

Open publisher page 12 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 12 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Prasugrel, Clopidogrel, Medicine, P2Y12, Percutaneous coronary intervention, Conventional PCI, Loading dose, Internal medicine

Back to paper search Browse research topics Original source

Pharmacodynamic effect of prasugrel 5 mg vs clopidogrel 150 mg in elderly patients with high on-clopidogrel platelet reactivity — Research Paper | ScholarLens